Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential TherapeuticsM. Manning, Gilles Guillon, Aleksandra Misicka et al.|Journal of Neuroendocrinology|2012Cited by 424
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆M. Manning, Gilles Guillon, Bernard Mouillac et al.|Progress in brain research|2008Cited by 289
Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacologyBice Chini, Gilles Guillon, M. Manning|Progress in brain research|2008Cited by 64
Pharmacological and Physiological Characterization of d[Leu4, Lys8]Vasopressin, the First V1b-Selective Agonist for Rat Vasopressin/Oxytocin ReceptorsAna Peña, Gilles Guillon|Endocrinology|2007Cited by 32
Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology DatabaseDaniel G. Bichet, Hans H. Zingg, Michel Bouvier et al.|IUPHAR/BPS Guide to Pharmacology CITE|2019Cited by 8